The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
101 jobs Number of planned job losses
Announcement Date
7 January 2008
Employment effect (start)
1 April 2008
Foreseen end date
Description
Roche, one of the world’s leading healthcare companies, has announced that it is to cut 101 jobs out of 1,900 workers employed in Italy. The job cuts will mainly affect the sales division of the company and are included in the reorganisation plan that the Roche Italia announced in January 2008. In Italy, Roche has more than 1,000 salesmen and two plants (the biggest one is located at Segrate, in the province of Milan, and it employs around 400 workers).
On 18 March 2008, Roche Italia announced an agreement with Innovex srl, one the world’s leading contract sales organisation, providing pharmaceutical, biotechnology and medical device customers with sales solutions. The agreement provides the joint management of marketing and sales’ activities for five Roche pharmaceutical products. Moreover, the agreement envisages that 51 out of 101 redundant workers will be hired by Innovex srl. The trade unions have expressed their satisfaction with the contents of the agreement.
The Roche group is a leading healthcare company in the fields of pharmaceuticals and diagnostics. It employs around 78,000 people and sells its products in over 150 countries. In Italy, it employs around 1,900 people.
Sources
19 March 2008: Il Sole 24 Ore
Citation
Eurofound (2008), Roche Italia, Internal restructuring in Italy, factsheet number 66437, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/66437.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...